Detalles de la búsqueda
1.
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
Mult Scler;
24(11): 1469-1484, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28799444
2.
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
BMC Cancer;
17(1): 852, 2017 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29241450
3.
Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels.
Leuk Lymphoma;
61(6): 1475-1483, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32064987
4.
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
Clin Lymphoma Myeloma Leuk;
19(4): 213-219.e4, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770308
5.
Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism.
Mov Disord;
23(13): 1860-6, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18759356
6.
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemia.
Leuk Lymphoma;
58(6): 1412-1423, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27739920
7.
The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury.
J Neurotrauma;
22(12): 1428-43, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16379581
8.
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
Int Clin Psychopharmacol;
27(3): 142-50, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22302014
9.
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
Lancet Neurol;
10(10): 881-90, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21889410
Resultados
1 -
9
de 9
1
Próxima >
>>